EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Determinants of Maternal RSV Vaccination Uptake: A Narrative Review

Aikaterini I Nikolaou iD, Alexandra Soldatou iD, Georgia-Christiana Grantzi, Vasileios Giapros, Fani Ladomenou iD

Vaccines · 26.03.2026 · 14 (4) · 293

DOI: 10.3390/vaccines14040293 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 26.03.2026. Verfasst von Aikaterini I Nikolaou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, School of Medicine, University of Ioannina, 45500 Ioannina, Greece. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maternal vaccination against respiratory syncytial virus (RSV) represents a major advance in early-life infection prevention. Although clinical efficacy and early real-world effectiveness are well established, sustained population-level impact depends on equitable uptake. This review synthesizes determinants influencing maternal RSV vaccination within the evolving dual-strategy landscape that includes both maternal vaccination and infant monoclonal antibody prophylaxis. A structured narrative review was conducted following PRISMA principles. PubMed/MEDLINE and Google Scholar were searched for studies published between January 2022 and February 2026. Eligible studies examined behavioral, interpersonal, structural, economic, and policy determinants of maternal RSV vaccination uptake, as well as early implementation and modelling evidence. Findings were integrated within a multilevel analytical framework. Maternal uptake is shaped by interacting determinants across individual, healthcare provider, and health system domains. Key drivers include perceived infant disease severity, vaccine safety confidence, perceived effectiveness, and prior antenatal vaccination behavior. Healthcare provider recommendation consistently emerges as the strongest facilitator. Coverage variability reflects differences in reimbursement, antenatal care integration, and national policy endorsement. The coexistence of maternal vaccination and infant monoclonal antibody strategies introduces additional comparative decision-making complexity. Early implementation data indicate heterogeneous uptake and socioeconomic gradients, while modelling demonstrates sensitivity to coverage, timing, epidemiology, and cost. Translating biological efficacy into sustained public health benefit requires coordinated behavioral, structural, and policy strategies, strong provider engagement, and context-sensitive implementation frameworks to ensure equitable coverage.

Schlagwörter

Stichwörter der Autor:innen

health equityhealth services accessibilitymaternal vaccinationmonoclonal antibodiespregnancyrespiratory syncytial virusvaccine hesitancyvaccine uptake

Autor:innen und Institutionen

  • Department of Pediatrics, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
  • Neonatal Intensive Care Unit, School of Medicine, University of Ioannina, 45500 Ioannina, Greece.
  • Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, 15772 Athens, Greece.
  • Evangelismos General Hospital, 10676 Athens, Greece.

ORCID-Profile: Aikaterini I Nikolaou, Alexandra Soldatou, Fani Ladomenou

Zitieren

APA

Nikolaou, A. I., Soldatou, A., Grantzi, G. C., Giapros, V., & Ladomenou, F. (2026). Determinants of Maternal RSV Vaccination Uptake: A Narrative Review. Vaccines, 14(4), 293. https://doi.org/10.3390/vaccines14040293

Vancouver

Nikolaou AI, Soldatou A, Grantzi GC, Giapros V, Ladomenou F. Determinants of Maternal RSV Vaccination Uptake: A Narrative Review. Vaccines. 2026;14(4):293. doi:10.3390/vaccines14040293

BibTeX
@article{Nikolaou2026,
  author = {Nikolaou, Aikaterini I and Soldatou, Alexandra and Grantzi, Georgia-Christiana and Giapros, Vasileios and Ladomenou, Fani},
  title = {Determinants of Maternal RSV Vaccination Uptake: A Narrative Review},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {293},
  doi = {10.3390/vaccines14040293}
}
Kostenlos starten →